Unlocking the Potential of Genetic Medicines Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins. The company is developing a wholly-owned pipeline of Centyrin-based therapeutic candidates and is working with industry partners to leverage Centyrins for tissue-specific targeting of therapeutics for a diverse set of diseases.
Location: United States, Pennsylvania, Philadelphia
Employees: 11-50
Total raised: $65.5M
Founded date: 2018
Investors 1
| Date | Name | Website |
| - | BioMotiv | biomotiv.c... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 28.11.2023 | Series B | $41.5M | - |
| 11.12.2022 | Series B | $24M | - |
Mentions in press and media 17
| Date | Title | Description | Source |
| 20.12.2023 | Philly Money Moves: Biotech firm Vivodyne raised $38M for la... | Money Moves is a column where we chart the raises, mergers and other funding news of tech companies ... | technical.... |
| 28.11.2023 | Aro Biotherapeutics Raises $41.5M Series B Financing | Aro Biotherapeutics, a Philadelphia, PA-based clinical stage biotechnology company, raised $41.5M in... | finsmes.co... |
| 05.01.2023 | Monday Moves: 3 Philly biotech companies are starting 2023 w... | Money Moves is a column where we chart the funding raises of tech companies across the region. Have ... | technical.... |
| 16.09.2022 | Aro Biotherapeutics Receives FDA Rare Pediatric Drug Designa... | Philadelphia, PA, September 15, 2022 — Aro Biotherapeutics, a biotechnology company pioneering the d... | healthcap.... |
| 11.08.2022 | Aro Biotherapeutics Receives FDA Orphan Drug Designation for... | PHILADELPHIA, PA., AUGUST 10, 2022 – Aro Biotherapeutics, a biotechnology company pioneering the dev... | healthcap.... |
| 11.05.2022 | Aro Biotherapeutics to Present New Preclinical Data Highligh... | Results of recent studies demonstrate that Aro’s muscle-targeted Centyrin-siRNA conjugate robustly r... | healthcap.... |
| 31.03.2022 | Aro Biotherapeutics to Highlight Therapeutic Potential of Ce... | Company to Present New Data Demonstrating Centyrin Oligonucleotide Conjugates Achieve Potent and Tis... | healthcap.... |
| 06.01.2021 | Daily funding roundup - January 5th, 2021 | Blue Wire raised $5M; Emboline landed $10M; PostHog secured $12M; Citizen pickes up $73M Care Packa... | vator.tv/n... |
| 05.01.2021 | Philly life science orgs see leadership changes, strong fund... | Power Moves is a column where we chart the comings and goings of talent across the region. Got a new... | technical.... |
| 05.01.2021 | Aro Biotherapeutics Raises $88M in Series A Financing | Aro Biotherapeutics, a Philadelphia, PA-based biotechnology company pioneering the development of ti... | finsmes.co... |
Show more